Page last updated: 2024-08-23

etomidate and Learning Disabilities

etomidate has been researched along with Learning Disabilities in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eger, EI; Jurd, R; Laha, KT; Lor, C; Oh, I; Pearce, RA; Rau, V; Rodgers, FC; Rudolph, U; Zarnowska, ED	1

Other Studies

1 other study(ies) available for etomidate and Learning Disabilities

Article	Year
Etomidate blocks LTP and impairs learning but does not enhance tonic inhibition in mice carrying the N265M point mutation in the beta3 subunit of the GABA(A) receptor. Neuropharmacology, 2015, Volume: 93 Topics: Animals; Conditioning, Classical; Dose-Response Relationship, Drug; Etomidate; GABA Antagonists; HEK293 Cells; Hippocampus; Humans; Hypnotics and Sedatives; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Learning Disabilities; Long-Term Potentiation; Male; Mice; Mice, Transgenic; Neural Inhibition; Picrotoxin; Point Mutation; Pyramidal Cells; Receptors, GABA-A	2015

Article

Year

Etomidate blocks LTP and impairs learning but does not enhance tonic inhibition in mice carrying the N265M point mutation in the beta3 subunit of the GABA(A) receptor.

Neuropharmacology, 2015, Volume: 93

Topics: Animals; Conditioning, Classical; Dose-Response Relationship, Drug; Etomidate; GABA Antagonists; HEK293 Cells; Hippocampus; Humans; Hypnotics and Sedatives; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Learning Disabilities; Long-Term Potentiation; Male; Mice; Mice, Transgenic; Neural Inhibition; Picrotoxin; Point Mutation; Pyramidal Cells; Receptors, GABA-A

2015